205 related articles for article (PubMed ID: 26512138)
1. Revisiting the Timing of Action of the PAG Adaptor Using Quantitative Proteomics Analysis of Primary T Cells.
Reginald K; Chaoui K; Roncagalli R; Beau M; Goncalves Menoita M; Monsarrat B; Burlet-Schiltz O; Malissen M; Gonzalez de Peredo A; Malissen B
J Immunol; 2015 Dec; 195(11):5472-81. PubMed ID: 26512138
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation-dependent regulation of T-cell activation by PAG/Cbp, a lipid raft-associated transmembrane adaptor.
Davidson D; Bakinowski M; Thomas ML; Horejsi V; Veillette A
Mol Cell Biol; 2003 Mar; 23(6):2017-28. PubMed ID: 12612075
[TBL] [Abstract][Full Text] [Related]
3. Positive and Negative Regulatory Roles of C-Terminal Src Kinase (CSK) in FcεRI-Mediated Mast Cell Activation, Independent of the Transmembrane Adaptor PAG/CSK-Binding Protein.
Potuckova L; Draberova L; Halova I; Paulenda T; Draber P
Front Immunol; 2018; 9():1771. PubMed ID: 30116247
[TBL] [Abstract][Full Text] [Related]
4. Phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adaptor protein, binds the protein tyrosine kinase csk and is involved in regulation of T cell activation.
Brdicka T; Pavlistová D; Leo A; Bruyns E; Korínek V; Angelisová P; Scherer J; Shevchenko A; Hilgert I; Cerný J; Drbal K; Kuramitsu Y; Kornacker B; Horejsí V; Schraven B
J Exp Med; 2000 May; 191(9):1591-604. PubMed ID: 10790433
[TBL] [Abstract][Full Text] [Related]
5. Removal of C-terminal SRC kinase from the immune synapse by a new binding protein.
Rahmouni S; Vang T; Alonso A; Williams S; van Stipdonk M; Soncini C; Moutschen M; Schoenberger SP; Mustelin T
Mol Cell Biol; 2005 Mar; 25(6):2227-41. PubMed ID: 15743820
[TBL] [Abstract][Full Text] [Related]
6. The Csk-Associated Adaptor PAG Inhibits Effector T Cell Activation in Cooperation with Phosphatase PTPN22 and Dok Adaptors.
Davidson D; Zhong MC; Pandolfi PP; Bolland S; Xavier RJ; Seed B; Li X; Gu H; Veillette A
Cell Rep; 2016 Dec; 17(10):2776-2788. PubMed ID: 27926878
[TBL] [Abstract][Full Text] [Related]
7. PAG-associated FynT regulates calcium signaling and promotes anergy in T lymphocytes.
Davidson D; Schraven B; Veillette A
Mol Cell Biol; 2007 Mar; 27(5):1960-73. PubMed ID: 17210649
[TBL] [Abstract][Full Text] [Related]
8. Cutting edge: Fyn is essential for tyrosine phosphorylation of Csk-binding protein/phosphoprotein associated with glycolipid-enriched microdomains in lipid rafts in resting T cells.
Yasuda K; Nagafuku M; Shima T; Okada M; Yagi T; Yamada T; Minaki Y; Kato A; Tani-Ichi S; Hamaoka T; Kosugi A
J Immunol; 2002 Sep; 169(6):2813-7. PubMed ID: 12218089
[TBL] [Abstract][Full Text] [Related]
9. Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors.
Freeburn RW; Wright KL; Burgess SJ; Astoul E; Cantrell DA; Ward SG
J Immunol; 2002 Nov; 169(10):5441-50. PubMed ID: 12421919
[TBL] [Abstract][Full Text] [Related]
10. Protein tyrosine phosphatase alpha regulates Fyn activity and Cbp/PAG phosphorylation in thymocyte lipid rafts.
Maksumova L; Le HT; Muratkhodjaev F; Davidson D; Veillette A; Pallen CJ
J Immunol; 2005 Dec; 175(12):7947-56. PubMed ID: 16339530
[TBL] [Abstract][Full Text] [Related]
11. Subcellular distribution of Lck during CD4 T-cell maturation in the thymic medulla regulates the T-cell activation threshold.
Stephen TL; Wilson BS; Laufer TM
Proc Natl Acad Sci U S A; 2012 May; 109(19):7415-20. PubMed ID: 22529380
[TBL] [Abstract][Full Text] [Related]
12. A human CD4 monoclonal antibody for the treatment of T-cell lymphoma combines inhibition of T-cell signaling by a dual mechanism with potent Fc-dependent effector activity.
Rider DA; Havenith CE; de Ridder R; Schuurman J; Favre C; Cooper JC; Walker S; Baadsgaard O; Marschner S; vandeWinkel JG; Cambier J; Parren PW; Alexander DR
Cancer Res; 2007 Oct; 67(20):9945-53. PubMed ID: 17942927
[TBL] [Abstract][Full Text] [Related]
13. Physical association of CD4 and CD45 in primary, resting CD4+ T cells.
Bonnard M; Maroun CR; Julius M
Cell Immunol; 1997 Jan; 175(1):1-11. PubMed ID: 9015182
[TBL] [Abstract][Full Text] [Related]
14. Spatiotemporal control of cyclic AMP immunomodulation through the PKA-Csk inhibitory pathway is achieved by anchoring to an Ezrin-EBP50-PAG scaffold in effector T cells.
Cornez I; Taskén K
FEBS Lett; 2010 Jun; 584(12):2681-8. PubMed ID: 20420835
[TBL] [Abstract][Full Text] [Related]
15. Aberrant TCR-mediated signaling in CD45-null thymocytes involves dysfunctional regulation of Lck, Fyn, TCR-zeta, and ZAP-70.
Stone JD; Conroy LA; Byth KF; Hederer RA; Howlett S; Takemoto Y; Holmes N; Alexander DR
J Immunol; 1997 Jun; 158(12):5773-82. PubMed ID: 9190928
[TBL] [Abstract][Full Text] [Related]
16. Targeting of CD45 protein tyrosine phosphatase activity to lipid microdomains on the T cell surface inhibits TCR signaling.
He X; Woodford-Thomas TA; Johnson KG; Shah DD; Thomas ML
Eur J Immunol; 2002 Sep; 32(9):2578-87. PubMed ID: 12207342
[TBL] [Abstract][Full Text] [Related]
17. Autonomous maturation of alpha/beta T lineage cells in the absence of COOH-terminal Src kinase (Csk).
Schmedt C; Tarakhovsky A
J Exp Med; 2001 Apr; 193(7):815-26. PubMed ID: 11283154
[TBL] [Abstract][Full Text] [Related]
18. A dual participation of ZAP-70 and scr protein tyrosine kinases is required for TCR-induced tyrosine phosphorylation of Sam68 in Jurkat T cells.
Lang V; Mège D; Semichon M; Gary-Gouy H; Bismuth G
Eur J Immunol; 1997 Dec; 27(12):3360-7. PubMed ID: 9464824
[TBL] [Abstract][Full Text] [Related]
19. Perturbed regulation of ZAP-70 and sustained tyrosine phosphorylation of LAT and SLP-76 in c-Cbl-deficient thymocytes.
Thien CB; Bowtell DD; Langdon WY
J Immunol; 1999 Jun; 162(12):7133-9. PubMed ID: 10358158
[TBL] [Abstract][Full Text] [Related]
20. Quantitative proteomics analysis of signalosome dynamics in primary T cells identifies the surface receptor CD6 as a Lat adaptor-independent TCR signaling hub.
Roncagalli R; Hauri S; Fiore F; Liang Y; Chen Z; Sansoni A; Kanduri K; Joly R; Malzac A; Lähdesmäki H; Lahesmaa R; Yamasaki S; Saito T; Malissen M; Aebersold R; Gstaiger M; Malissen B
Nat Immunol; 2014 Apr; 15(4):384-392. PubMed ID: 24584089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
